Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $55.0000 (-11.29%) ($52.7000 - $61.0000) on Wed. Feb. 4, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.22% (three month average) | RSI | 69 | Latest Price | $55.0000(-11.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 24.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -3.11% in a week (0% probabilities). VIXM(-5%) TLT(-3%) SLV(-2%) GLD(-2%) BND(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.11% (StdDev 6.22%) | Hourly BBV | 0 () | Intraday Trend | 4.3% | | | |
|
5 Day Moving Average | $61.02(-9.87%) | 10 Day Moving Average | $56.36(-2.41%) | 20 Day Moving Average | $47.48(15.84%) | To recent high | -16.2% | To recent low | 61.8% | Market Cap | $1.083b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |